Neuravi
Treatment of acute ischemic stroke.
Launch date
Employees
Market cap
-
Enterprise valuation
€24—37m (Dealroom.co estimates Jul 2016.)
Company register number 468507
Galway County Galway (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 8.0m | 22.0m | 29.9m | 44.4m | 44.4m | 44.4m | 44.4m |
| % growth | 129 % | 175 % | 36 % | 48 % | - | - | - |
| EBITDA | (12.1m) | 4.4m | 2.0m | 13.8m | - | - | - |
| % EBITDA margin | (152 %) | 20 % | 7 % | 31 % | - | - | - |
| Profit | (9.4m) | 3.6m | <1m | 13.7m | - | - | - |
| % profit margin | (117 %) | 16 % | 3 % | 31 % | - | - | - |
| R&D budget | 5.0m | - | - | - | - | - | - |
| R&D % of revenue | 62 % | - | - | - | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€5.2m | Series A | ||
€19.0m | Series B | ||
| N/A | €6.1m | Series C | |
* | €15.0m | Debt | |
| Total Funding | €30.3m | ||
Recent News about Neuravi
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.